Cargando…

Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption

Abnormalities of bone turnover are commonly observed in patients with chronic kidney disease (CKD), and the low‐turnover bone disease is considered to be associated with low serum parathyroid hormone (PTH) levels and skeletal resistance to PTH. Indoxyl sulfate (IS) is a representative uremic toxin t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Kenta, Tominari, Tsukasa, Hirata, Michiko, Matsumoto, Chiho, Hirata, Junya, Murphy, Gillian, Nagase, Hideaki, Miyaura, Chisato, Inada, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536993/ https://www.ncbi.nlm.nih.gov/pubmed/28781957 http://dx.doi.org/10.1002/2211-5463.12258

Ejemplares similares

Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced inflammatory bone resorption, and protects against alveolar bone loss in mice
por: Tominari, Tsukasa, et al.
Publicado: (2015)

Capsaicin, a TRPV1 Ligand, Suppresses Bone Resorption by Inhibiting the Prostaglandin E Production of Osteoblasts, and Attenuates the Inflammatory Bone Loss Induced by Lipopolysaccharide
por: Kobayashi, Megumi, et al.
Publicado: (2012)

Effects of O‐methylated (−)‐epigallocatechin gallate (EGCG) on LPS‐induced osteoclastogenesis, bone resorption, and alveolar bone loss in mice
por: Tominari, Tsukasa, et al.
Publicado: (2017)

Beta-Cryptoxanthin Inhibits Lipopolysaccharide-Induced Osteoclast Differentiation and Bone Resorption via the Suppression of Inhibitor of NF-κB Kinase Activity
por: Hirata, Narumi, et al.
Publicado: (2019)

Endosomal TLR3 signaling in stromal osteoblasts induces prostaglandin E(2)–mediated inflammatory periodontal bone resorption
por: Tominari, Tsukasa, et al.
Publicado: (2022)

Effects of Polymethoxyflavonoids on Bone Loss Induced by Estrogen Deficiency and by LPS-Dependent Inflammation in Mice
por: Matsumoto, Shigeru, et al.
Publicado: (2018)

Gram-positive bacteria cell wall-derived lipoteichoic acid induces inflammatory alveolar bone loss through prostaglandin E production in osteoblasts
por: Tominari, Tsukasa, et al.
Publicado: (2021)

Effects of 4′-Demethylnobiletin and 4′-Demethyltangeretin on Osteoclast Differentiation In Vitro and in a Mouse Model of Estrogen-Deficient Bone Resorption
por: Hirata, Michiko, et al.
Publicado: (2023)

Hypergravity and microgravity exhibited reversal effects on the bone and muscle mass in mice
por: Tominari, Tsukasa, et al.
Publicado: (2019)

Binding Affinity and Capacity for the Uremic Toxin Indoxyl Sulfate
por: Devine, Eric, et al.
Publicado: (2014)

Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate
por: Ahmed, Mohamed Siyabeldin E, et al.
Publicado: (2013)

Neurobehavioral effects of uremic toxin–indoxyl sulfate in the rat model
por: Karbowska, Malgorzata, et al.
Publicado: (2020)

A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology
por: Tanaka, Ryo, et al.
Publicado: (2022)

Indoxyl Sulfate, a Uremic Endotheliotoxin
por: Lano, Guillaume, et al.
Publicado: (2020)

The Uremic Toxin Indoxyl Sulfate Accelerates Senescence in Kidney Proximal Tubule Cells
por: Yang, Yi, et al.
Publicado: (2023)

An Essential Role of Cytosolic Phospholipase A2α in Prostaglandin E2–mediated Bone Resorption Associated with Inflammation
por: Miyaura, Chisato, et al.
Publicado: (2003)

Effects of Sevelamer Hydrochloride on Uremic Toxins Serum Indoxyl Sulfate and P-Cresyl Sulfate in Hemodialysis Patients
por: Lin, Cheng-Jui, et al.
Publicado: (2017)

Uremic Toxin Indoxyl Sulfate Impairs Hydrogen Sulfide Formation in Renal Tubular Cells
por: Lu, Chien-Lin, et al.
Publicado: (2022)

SLC22A11 Inserts the Uremic Toxins Indoxyl Sulfate and P-Cresol Sulfate into the Plasma Membrane
por: Tust, Maurice, et al.
Publicado: (2023)

Podocyte Injury Caused by Indoxyl Sulfate, a Uremic Toxin and Aryl-Hydrocarbon Receptor Ligand
por: Ichii, Osamu, et al.
Publicado: (2014)

The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models
por: Karbowska, Malgorzata, et al.
Publicado: (2017)

TRPV1 Hyperfunction Involved in Uremic Toxin Indoxyl Sulfate-Mediated Renal Tubular Damage
por: Lu, Chien-Lin, et al.
Publicado: (2020)

Uremic toxin indoxyl sulfate promotes proinflammatory macrophage activation by regulation of β-catenin and YAP pathways
por: Li, Ying, et al.
Publicado: (2021)

Gut-Derived Uremic Toxins in CKD: An Improved Approach for the Evaluation of Serum Indoxyl Sulfate in Clinical Practice
por: Caggiano, Gianvito, et al.
Publicado: (2023)

Uremic Toxin Indoxyl Sulfate Promotes Macrophage-Associated Low-Grade Inflammation and Epithelial Cell Senescence
por: Ribeiro, Andrea, et al.
Publicado: (2023)

The Uremic Toxin Indoxyl Sulphate Enhances Macrophage Response to LPS
por: Adesso, Simona, et al.
Publicado: (2013)

Effects of the uremic toxin indoxyl sulphate on human microvascular endothelial cells
por: Colombo, Graziano, et al.
Publicado: (2022)

Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB
por: Bolati, Dilinaer, et al.
Publicado: (2013)

Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease
por: Kamiński, Tomasz W., et al.
Publicado: (2017)

Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression
por: Takada, T., et al.
Publicado: (2018)

Functional Genomic Analysis Identifies Indoxyl Sulfate as a Major, Poorly Dialyzable Uremic Toxin in End-Stage Renal Disease
por: Jhawar, Sachin, et al.
Publicado: (2015)

Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure
por: Di Paola, Rossella, et al.
Publicado: (2023)

Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uremic Toxin, Indoxyl Sulfate
por: Lekawanvijit, Suree, et al.
Publicado: (2012)

The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease
por: Kaminski, Tomasz W., et al.
Publicado: (2019)

Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease
por: Sato, Emiko, et al.
Publicado: (2016)

Lactobacillus salivarius BP121 prevents cisplatin-induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p-cresol sulfate via alleviating dysbiosis
por: Lee, Tae-Hee, et al.
Publicado: (2020)

Uremic Retention Solute Indoxyl Sulfate Level Is Associated with Prolonged QTc Interval in Early CKD Patients
por: Tang, Wei-Hua, et al.
Publicado: (2015)

Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature
por: Brydges, Christopher R., et al.
Publicado: (2021)

Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease
por: Cheng, Tong-Hong, et al.
Publicado: (2020)

Possible role of S-equol on bone loss via amelioration of inflammatory indices in ovariectomized mice
por: Nishide, Yoriko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i6q5obg3hdbioh9e6ffdb8mqgh